1
|
Duarte IDAE, Milenkovic D, Borges TKDS, Rosa AJDM, Morand C, de Oliveira LDL, Costa AM. Acute Effects of the Consumption of Passiflora setacea Juice on Metabolic Risk Factors and Gene Expression Profile in Humans. Nutrients 2020; 12:nu12041104. [PMID: 32316129 PMCID: PMC7231153 DOI: 10.3390/nu12041104] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Revised: 03/26/2020] [Accepted: 03/31/2020] [Indexed: 12/15/2022] Open
Abstract
Background: Passiflora setacea (PS) is a passionfruit variety of the Brazilian savannah and is a rich source of plant food bioactives with potential anti-inflammatory activity. This study aimed to investigate the effect of an acute intake of PS juice upon inflammation, metabolic parameters, and gene expression on circulating immune cells in humans. Methods: Overweight male volunteers (n = 12) were enrolled in two double-blind placebo-controlled studies. Blood samples were collected from fasting volunteers 3 h after the consumption of 250 mL of PS juice or placebo (PB). Metabolic parameters (insulin, glucose, total cholesterol, high-density lipoprotein (LDL), high-density lipoprotein (HDL), and total triglycerides) and circulating cytokines were evaluated (study 1). Peripheral blood mononuclear cell (PBMC) from the same subjects were isolated and RNA was extracted for transcriptomic analyses using microarrays (study 2). Results: Insulin and homeostatic model assessment for insulin resistance (HOMA-IR) levels decreased statistically after the PS juice intake, whereas HDL level increased significantly. Interleukin (IL)-17A level increased after placebo consumption, whereas its level remained unchanged after PS juice consumption. Nutrigenomic analyses revealed 1327 differentially expressed genes after PS consumption, with modulated genes involved in processes such as inflammation, cell adhesion, or cytokine–cytokine receptor. Conclusion: Taken together, these clinical results support the hypothesis that PS consumption may help the prevention of cardiometabolic diseases.
Collapse
Affiliation(s)
- Isabella de Araújo Esteves Duarte
- Postgraduate Program in Human Nutrition, College of Health Sciences, Campus Universitário Darcy Ribeiro, Universidade de Brasília, Brasília DF 70.910-900, Brazil;
- Correspondence: ; Tel.: +55-61-99996-8004
| | - Dragan Milenkovic
- Unité de Nutrition Humaine, Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont-Ferrand, France; (D.M.); (C.M.)
- Department of Internal Medicine, Division of Cardiovascular Medicine, School of Medicine, University of California Davis, Davis, CA 95616, USA
| | | | | | - Christine Morand
- Unité de Nutrition Humaine, Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont-Ferrand, France; (D.M.); (C.M.)
| | - Livia de Lacerda de Oliveira
- Postgraduate Program in Human Nutrition, College of Health Sciences, Campus Universitário Darcy Ribeiro, Universidade de Brasília, Brasília DF 70.910-900, Brazil;
| | - Ana Maria Costa
- Laboratory of Food Science, Embrapa Cerrados, Planaltina DF 73.310-970, Brazil; (A.J.d.M.R.); (A.M.C.)
| |
Collapse
|
2
|
Xi S, Fu B, Loy G, Minuk GY, Peng Y, Qiu Y, Zhai X, Wang Y, Li P, Gong Y, Wang J, Huang S, Lu D, Wang Y. The effects of Ciji-Hua'ai-Baosheng on immune function of mice with H 22 hepatocellular carcinoma receiving chemotherapy. Biomed Pharmacother 2018; 101:898-909. [PMID: 29635899 DOI: 10.1016/j.biopha.2018.03.027] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2017] [Revised: 03/06/2018] [Accepted: 03/06/2018] [Indexed: 01/12/2023] Open
Abstract
BACKGROUND Ciji-Hua'ai-Baosheng Decoction (CHBD) is a traditional Chinese formula that may attenuate the toxicity and side-effects of chemotherapy. The formula may also prolong the life of cancer patients. Whether CHBD should be employed as adjunctive therapy for cancer patients receiving chemotherapy has yet to be determined as does the mechanism whereby CHBD exerts its beneficial effects. AIM OF THE STUDY To document the potential effects of CHBD on tumor growth and immune function in a murine model of hepatocellular carcinoma (HCC) receiving chemotherapy. MATERIALS AND METHODS Sixty Kunming mice were injected subcutaneously with H22 hepatoma cells in the right anterior armpit. After seven days, the mice with formed tumors were injected with Cytoxan (CTX) (200 mg/kg) to establish the chemotherapy model. These mice were randomly divided into 5 groups: model (untreated controls), control (CTX,33.33 mg/kg), and high CHBD (H) (117 g/kg), moderate CHBD (M) (58.5 g/kg) and low CHBD (L) (29.25 g/kg) treated groups. Tumor weights and inhibitory ratio (decrease in tumor dimensions), histology of tumor, colon, spleen and liver, and biochemical tests of liver and kidney function were documented after 10 days. Serum and tumor IL-2, IFN-γ, IL-6, and TNF-α levels were determined by enzyme-linked immunosorbent assay (ELISA) and Western blot respectively. The potential bioactive compounds in CHBD were characterized by UHPLC-MS. RESULTS Although tumor weights were decreased in CTX alone and CHBD (H) and CHBD (M) groups (-66%, -41% and -25% respectively), tumor cell density was reduced to the greatest extent in the CHBD (H) group. CHBD had no evident effects on liver and kidney function. CTX-induced colon inflammation and decrease in spleen lymphocytes were attenuated with CHBD treatment. CHBD increased serum IL-2, IFN-γ and TNF-α, but decreased IL-6 levels in serum and tumor tissue. UHPLC-MS analysis of CHBD revealed the presence of 11 bioactive compounds. CONCLUSIONS In this murine model of HCC receiving chemotherapy, CHBD inhibited tumor growth, improved immune function and pro-inflammatory cytokine responses while attenuating CTX-associated side effects.
Collapse
Affiliation(s)
- Shengyan Xi
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China; Xiamen Key Laboratory for TCM Dampness Disease, Neurology & Immunology Research, Xiamen, 361102 Fujian Province, People's Republic of China.
| | - Biqian Fu
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Guanjie Loy
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Gerald Y Minuk
- Department of Internal Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, R3E 3P4 Manitoba, Canada
| | - Ying Peng
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Yinkun Qiu
- School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102 Fujian Province, People's Republic of China
| | - Xiangyang Zhai
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Yujie Wang
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Pengfei Li
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Yuewen Gong
- College of Pharmacy, University of Manitoba, Winnipeg, R3E 0T5 Manitoba, Canada
| | - Jing Wang
- School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102 Fujian Province, People's Republic of China
| | - Shuqiong Huang
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Dawei Lu
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China
| | - Yanhui Wang
- Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen 361102, Fujian Province, People's Republic of China; Xiamen Key Laboratory for TCM Dampness Disease, Neurology & Immunology Research, Xiamen, 361102 Fujian Province, People's Republic of China.
| |
Collapse
|